Luca Lo Nigro

Summary

Publications

  1. ncbi request reprint Occurrence of a FAB-M1 AML in a child during treatment of APL: emergence of an immature clone or a therapy related-AML?
    Luca Lo Nigro
    Center of Pediatric Hematology Oncology, University of Catania, Via S Sofia 78, 95123 Catania, Italy
    Haematologica 87:ELT26. 2002
  2. doi request reprint Biology of childhood acute lymphoblastic leukemia
    Luca Lo Nigro
    Head of Cytogenetic and Molecular Biology Laboratory for Onco Hematological Disease, Center of Pediatric Hematology Oncology, Azienda Policlinico OVE, Catania, Italy
    J Pediatr Hematol Oncol 35:245-52. 2013
  3. ncbi request reprint Association of cytogenetic abnormalities with detection of BCR-ABL fusion transcripts in children with T-lineage lymphoproliferative diseases (T-ALL and T-NHL)
    Luca Lo Nigro
    Center of Pediatric Hematology and Oncology, University of Catania, Italy
    Pediatr Blood Cancer 42:278-80. 2004
  4. doi request reprint Clinical manifestations and management of four children with Pearson syndrome
    Manuela Tumino
    Pediatric Hematology and Oncology, University of Catania, Catania, Italy
    Am J Med Genet A 155:3063-6. 2011
  5. doi request reprint Simultaneous tumors: acute myeloid leukemia infiltrating mediastinal ganglioneuroblastoma
    Andrea Di Cataldo
    Department of Paediatric Haematology and Oncology, University of Catania, Catania, Italy
    Pediatr Blood Cancer 56:298-300. 2011
  6. ncbi request reprint Managing hepatosplenic gammadelta T-cell leukemia-lymphoma in children
    Luca Lo Nigro
    Pediatr Blood Cancer 49:763. 2007
  7. ncbi request reprint Marked osteoporosis and spontaneous vertebral fractures in children: don't forget, it could be leukemia
    Gregoria Bertuna
    Centro di Riferimento Regionale di Ematologia ed Oncologia Pediatrica, Universita di Catania, Italy
    Med Pediatr Oncol 41:450-1. 2003
  8. doi request reprint Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy
    Maurizio Arico
    Pediatric Hematology Oncology, Ospedale dei Bambini G Di Cristina, Palermo, Italy
    J Clin Oncol 26:283-9. 2008
  9. ncbi request reprint Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood
    Lara Mussolin
    Clinica di Oncoematologia Pediatrica, Azienda Ospedaliera Universita di Padova, Via Giustiniani 3, 35128 Padova, Italy
    J Clin Oncol 25:5254-61. 2007
  10. ncbi request reprint Prognostic impact of t(9;11) in childhood acute myeloid leukemia (AML)
    Luca Lo Nigro
    Leukemia 17:636. 2003

Collaborators

  • Andrea Di Cataldo
  • Maura Faraci
  • Maurizio Arico
  • Anna Maria Testi
  • Giuseppe Basso
  • Manuela Tumino
  • Lara Mussolin
  • Andrea Biondi
  • Giuseppe Masera
  • Franco Locatelli
  • Maria Grazia Valsecchi
  • Carmelo Rizzari
  • Andrea Pession
  • Gregoria Bertuna
  • Cinzia Castana
  • Milena La Spina
  • Vincenzo Di Raimondo
  • Concetta Meli
  • Piero Farruggia
  • Marivana Alfano
  • Giovanna Russo
  • Annarita Pittalà
  • Salvatore Buffardi
  • Valentino Conter
  • Matilde Piglione
  • Marta Pillon
  • Angelo Rosolen
  • Luigi Zanesco
  • Paolo Pierani
  • Concetta Micalizzi
  • Paola de Lorenzo
  • Giulio De Rossi
  • Elisabeth R van Wering
  • Willem A Kamps
  • Edina Magyarosy
  • Anna van der Does
  • Paolo Famà
  • Giovanna Russo-Mancuso

Detail Information

Publications13

  1. ncbi request reprint Occurrence of a FAB-M1 AML in a child during treatment of APL: emergence of an immature clone or a therapy related-AML?
    Luca Lo Nigro
    Center of Pediatric Hematology Oncology, University of Catania, Via S Sofia 78, 95123 Catania, Italy
    Haematologica 87:ELT26. 2002
  2. doi request reprint Biology of childhood acute lymphoblastic leukemia
    Luca Lo Nigro
    Head of Cytogenetic and Molecular Biology Laboratory for Onco Hematological Disease, Center of Pediatric Hematology Oncology, Azienda Policlinico OVE, Catania, Italy
    J Pediatr Hematol Oncol 35:245-52. 2013
    ..Finally, as future treatment will be individualized on the basis of biological features, the pediatric hemato-oncologists need to be ready and prepared to tailor the "right treatment" to the "right children" with ALL...
  3. ncbi request reprint Association of cytogenetic abnormalities with detection of BCR-ABL fusion transcripts in children with T-lineage lymphoproliferative diseases (T-ALL and T-NHL)
    Luca Lo Nigro
    Center of Pediatric Hematology and Oncology, University of Catania, Italy
    Pediatr Blood Cancer 42:278-80. 2004
    ....
  4. doi request reprint Clinical manifestations and management of four children with Pearson syndrome
    Manuela Tumino
    Pediatric Hematology and Oncology, University of Catania, Catania, Italy
    Am J Med Genet A 155:3063-6. 2011
    ..In this latter patient transplantation corrected hematological and non-hematological issues like metabolic acidosis, and we therefore argue that it could be considered as a useful option in an early stage of the disease...
  5. doi request reprint Simultaneous tumors: acute myeloid leukemia infiltrating mediastinal ganglioneuroblastoma
    Andrea Di Cataldo
    Department of Paediatric Haematology and Oncology, University of Catania, Catania, Italy
    Pediatr Blood Cancer 56:298-300. 2011
    ..Our observation suggests that in patients with more than one tumor, though discovered at different times, one neoplasm is not always secondary...
  6. ncbi request reprint Managing hepatosplenic gammadelta T-cell leukemia-lymphoma in children
    Luca Lo Nigro
    Pediatr Blood Cancer 49:763. 2007
  7. ncbi request reprint Marked osteoporosis and spontaneous vertebral fractures in children: don't forget, it could be leukemia
    Gregoria Bertuna
    Centro di Riferimento Regionale di Ematologia ed Oncologia Pediatrica, Universita di Catania, Italy
    Med Pediatr Oncol 41:450-1. 2003
  8. doi request reprint Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy
    Maurizio Arico
    Pediatric Hematology Oncology, Ospedale dei Bambini G Di Cristina, Palermo, Italy
    J Clin Oncol 26:283-9. 2008
    ..The prognostic value of DNA index was explored in this setting...
  9. ncbi request reprint Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood
    Lara Mussolin
    Clinica di Oncoematologia Pediatrica, Azienda Ospedaliera Universita di Padova, Via Giustiniani 3, 35128 Padova, Italy
    J Clin Oncol 25:5254-61. 2007
    ..To study the prevalence of t(8;14) at diagnosis and the response kinetics to treatment of minimal residual disease (MRD) in B-cell acute lymphoblastic leukemia (B-ALL) patients and determine its impact on prognosis...
  10. ncbi request reprint Prognostic impact of t(9;11) in childhood acute myeloid leukemia (AML)
    Luca Lo Nigro
    Leukemia 17:636. 2003
  11. ncbi request reprint Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia
    Andrea Pession
    Associazione Italiana di Ematologia Oncologia Pediatrica AIEOP, University of Bologna, Bologna, Italy
    J Clin Oncol 23:7161-7. 2005
    ....
  12. ncbi request reprint Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study
    Maurizio Arico
    Oncoematologia Pediatrica, Ospedale dei Bambini G Di Cristina, 90134 Palermo, Italy
    Haematologica 90:1186-91. 2005
    ..The aim of this study was to evaluate the efficacy of treatment reduction in a subset of children with ALL at minimal risk of failure...
  13. ncbi request reprint Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies
    Andrea Biondi
    Centro Ricerche Leucemie Infantili M Tettamanti, Clinica Pediatrica Università Milano Bicocca, Monza, Italy
    Haematologica 91:534-7. 2006
    ..The corresponding figures for patients treated in the ALL-91 high-risk protocol (reduced induction and nine blocks) were one of seven patients treated with chemotherapy only and none of two who were transplanted...